<DOC>
	<DOCNO>NCT00321399</DOCNO>
	<brief_summary>Three main clinical outcome assess : 1 . Post-test resource utilization assess referral rate catheterization within 90-days index study ; 2 . Incremental prognostic value risk stratification predict cardiac death myocardial infarction ; 3 . Cost-effectiveness To end , SPARC organize two distinct specific objective important difference patient population endpoint . Specific Aim 1 : To evaluate impact stress perfusion image SPECT PET , CT Angiography , hybrid PET-CT post-test resource utilization . The primary endpoint specific aim 1 compare impact combine myocardial perfusion-coronary anatomy data perfusion [ stress SPECT , stress cardiac PET ( without CTA ) ] anatomy ( CTA alone ) post-test resource utilization , measure referral cardiac catheterization within 90 day index noninvasive testing , patient without CAD . Secondary endpoint : 1. compare diagnostic accuracy detection epicardial CAD stress PET hybrid PET-CT , stress SPECT , CTA , define coronary angiography ; 2. compare referral rate revascularization within 90 day cardiac catheterization . Specific Aim 2 : To compare incremental prognostic value risk stratification stress perfusion image SPECT PET , CT coronary angiography , combine perfusion-anatomy imaging approach . The primary endpoint specific aim 2 compare incremental value stress perfusion ( stress PET stress SPECT ) , coronary anatomy ( CTA data ) , combine perfusion-anatomy study ( PET+CTA SPECT+CTA ) clinical , historical stress test data prediction cardiac death nonfatal myocardial infarction . Secondary endpoint : 1. compare incremental value noninvasive imaging approach clinical , historical stress test data prediction composite endpoint include cardiac death , nonfatal myocardial infarction , late ( &gt; 6 month index study ) referral revascularization , late ( &gt; 6 month index study ) hospitalization chest pain heart failure ; 2. compare incremental value noninvasive imaging approach clinical , historical stress test data prediction cause mortality . In addition , ability modality -together separately- risk stratify patient primary goal specific aim 2 .</brief_summary>
	<brief_title>Study Perfusion Anatomy 's Role Coronary Artery ( CAD )</brief_title>
	<detailed_description />
	<criteria>Referred clinical stress SPECT , stress PET , CTA PETCT study Intermediate high pretest likelihood CAD ( &gt; .25 ; define ACC/AHA Stable Angina Guidelines ) without prior MI/PCI/CABG . These consider diagnostic patient . Documented known CAD define prior MI/PCI/CABG Provide sign informed consent participate study Low pretest likelihood CAD ( &lt; =.25 ; define ACC/AHA Stable Angina Guidelines ) . Major concomitant noncardiac disease social condition/situation opinion investigator preclude patient participation study followup . Concurrent prior ( within last 30 day ) participation research study use investigational drug device . Presence permanent automate internal cardiac defibrillator ( AICD ) Known nonischemic cardiomyopathy Chest pain rest within 48 hour prior index noninvasive imaging test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>CORONARY ANATOMY</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>SPECT</keyword>
	<keyword>PET</keyword>
	<keyword>PET/CT</keyword>
	<keyword>CTA</keyword>
</DOC>